ATEC vs. GMED, MASI, TFX, ITGR, ATRC, IART, OFIX, SRDX, ANGO, and ARAY
Should you be buying Alphatec stock or one of its competitors? The main competitors of Alphatec include Globus Medical (GMED), Masimo (MASI), Teleflex (TFX), Integer (ITGR), AtriCure (ATRC), Integra LifeSciences (IART), Orthofix Medical (OFIX), Surmodics (SRDX), AngioDynamics (ANGO), and Accuray (ARAY). These companies are all part of the "health care equipment" industry.
Alphatec vs. Its Competitors
Alphatec (NASDAQ:ATEC) and Globus Medical (NYSE:GMED) are both mid-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, risk, earnings, profitability, media sentiment and institutional ownership.
66.4% of Alphatec shares are owned by institutional investors. Comparatively, 95.2% of Globus Medical shares are owned by institutional investors. 20.9% of Alphatec shares are owned by company insiders. Comparatively, 18.5% of Globus Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Alphatec has a beta of 1.05, meaning that its share price is 5% more volatile than the S&P 500. Comparatively, Globus Medical has a beta of 1.2, meaning that its share price is 20% more volatile than the S&P 500.
Globus Medical has higher revenue and earnings than Alphatec. Alphatec is trading at a lower price-to-earnings ratio than Globus Medical, indicating that it is currently the more affordable of the two stocks.
In the previous week, Globus Medical had 6 more articles in the media than Alphatec. MarketBeat recorded 18 mentions for Globus Medical and 12 mentions for Alphatec. Globus Medical's average media sentiment score of 1.52 beat Alphatec's score of 1.33 indicating that Globus Medical is being referred to more favorably in the news media.
Globus Medical has a net margin of 13.58% compared to Alphatec's net margin of -24.33%. Globus Medical's return on equity of 10.65% beat Alphatec's return on equity.
Alphatec presently has a consensus target price of $18.50, suggesting a potential upside of 15.41%. Globus Medical has a consensus target price of $87.64, suggesting a potential upside of 43.30%. Given Globus Medical's higher possible upside, analysts clearly believe Globus Medical is more favorable than Alphatec.
Summary
Globus Medical beats Alphatec on 13 of the 16 factors compared between the two stocks.
Get Alphatec News Delivered to You Automatically
Sign up to receive the latest news and ratings for ATEC and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding ATEC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Alphatec Competitors List
Related Companies and Tools
This page (NASDAQ:ATEC) was last updated on 8/28/2025 by MarketBeat.com Staff
MarketBeat All Access